Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Nitric Oxide in Chronic Rhinosinusitis
NCT04171167Active, not recruiting
- Sponsor
- Tampere University Hospital
- Start
- Apr 2017
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of fluticasone propionate in chronic rhinosinusitis (CRS) (4 arms), sponsored by Tampere University Hospital. Primary endpoints: Nasal nitric oxide levels at 10 weeks and Nitric oxide metabolite (nitrate, nitrite) levels at 10 weeks. Started Apr 2017; status: active, not recruiting.
02
Drugs
fluticasone propionate
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT04171167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04171167.